Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Drive. Miami, FL 33176, USA; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Thoracic Oncology Program, Grupo Oncoclínicas Grupo Oncoclínicas, Av. Pres. Juscelino Kubitschek, 510, 2º andar, São Paulo, São Paulo 04543-906, Brazil.
Hematol Oncol Clin North Am. 2024 Aug;38(4):813-830. doi: 10.1016/j.hoc.2024.04.001. Epub 2024 May 4.
This article explores the multifaceted landscape of oral cancer precursor syndromes. Hereditary disorders like dyskeratosis congenita and Fanconi anemia increase the risk of malignancy. Oral potentially malignant disorders, notably leukoplakia, are discussed as precursors influenced by genetic and immunologic facets. Molecular insights delve into genetic mutations, allelic imbalances, and immune modulation as key players in precancerous progression, suggesting potential therapeutic targets. The article navigates the controversial terrain of management strategies of leukoplakia, encompassing surgical resection, chemoprevention, and immune modulation, while emphasizing the ongoing challenges in developing effective, evidence-based preventive approaches.
本文探讨了口腔癌前综合征的多方面情况。先天性角化不良和范可尼贫血等遗传性疾病会增加恶性肿瘤的风险。口腔潜在恶性疾病,如白斑,被认为是受遗传和免疫因素影响的前体。分子研究深入探讨了遗传突变、等位基因失衡和免疫调节在癌前进展中的关键作用,提示了潜在的治疗靶点。文章还探讨了白斑病管理策略的争议领域,包括手术切除、化学预防和免疫调节,同时强调了开发有效、基于证据的预防方法所面临的持续挑战。